Author: Gómez-Aparicio, Maria Antonia; Valero, Jeannette; Caballero, Begoña; GarcÃa, Rafael; Hernando-Requejo, Ovidio; Montero, Ãngel; Gómez-Iturriaga, Alfonso; Zilli, Thomas; Ost, Piet; López-Campos, Fernando; Couñago, Felipe
Title: Extreme Hypofractionation with SBRT in Localized Prostate Cancer Cord-id: s4tj5tlm Document date: 2021_8_3
ID: s4tj5tlm
Snippet: Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a standard of care treatment option for men with localized prostate cancer. Over the years, radiation delivery modalities have contributed to increased precision of treatment, employing radiobiological insights to shorten the overall treatment time, improving the control of the disease without increasing toxicities. Stereotactic body radiation therapy (SBRT) represents an extreme form of hypofractio
Document: Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a standard of care treatment option for men with localized prostate cancer. Over the years, radiation delivery modalities have contributed to increased precision of treatment, employing radiobiological insights to shorten the overall treatment time, improving the control of the disease without increasing toxicities. Stereotactic body radiation therapy (SBRT) represents an extreme form of hypofractionated radiotherapy in which treatment is usually delivered in 1–5 fractions. This review assesses the main efficacy and toxicity data of SBRT in non-metastatic prostate cancer and discusses the potential to implement this scheme in routine clinical practice.
Search related documents:
Co phrase search for related documents- acceptable toxicity profile and local control: 1
- acceptable toxicity profile and low toxicity: 1, 2, 3
- acceptable toxicity profile and lymph node: 1, 2, 3
- acceptable toxicity profile and lymph node irradiation: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date